Optiscan Imaging Ltd is a global leader in the Health Care industry, offering digital microscopic imaging solutions. Founded in 1994 and headquartered in Australia, the company specializes in endomicroscopic digital imaging technology for medical, translational, and pre-clinical applications. Their unique technology enables real-time, 3D, in vivo imaging at the single-cell level, facilitating immediate informed decisions by clinicians without destructive processes. Optiscan's technology plays a crucial role in earlier disease detection and management, leading to improved patient outcomes and reduced healthcare costs. With their focus on delivering high-quality, live microscopic images and associated tools, the company aims to revolutionize healthcare by providing immediate informed decisions, economic efficiencies, and improved patient outcomes. In January 2013, Optiscan Imaging Ltd secured a significant $8.00M Post-IPO Debt investment. The company continues to attract investors while maintaining its position as a global leader in digital microscopic imaging.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Post-IPO Debt | $8.00M | - | 01 Jan 2013 |
No recent news or press coverage available for Optiscan Imaging Ltd.